Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Coronavirus Notebook: Remdesivir Enters Study, Outspoken Physician's Death Sparks Anger

Fri, 02/07/2020 - 12:30am

Gilead’s remdesivir is used for mild and moderate patients after an astonishing clinical approval in China, while the nation mourns...

      Related Stories 

Indian Pharma Monitoring Coronavirus Fallout On Production

Thu, 02/06/2020 - 10:45pm

With several Chinese manufacturing facilities shut at least till 10 February, Indian pharma companies are keeping a close watch on...

      Related Stories 

Cipla To Recalibrate US Investments, Partnering Plan For Specialty Business

Thu, 02/06/2020 - 8:59pm

Cipla to moderate investments across US generics R&D and specialty business, while its India business components - prescription, trade generic...

      Related Stories 

BMS Earnings Beat Estimates, But Opdivo Sales Slide Continues

Thu, 02/06/2020 - 2:51pm

The company believes the PD-1 inhibitor’s recent declines will be reversed through new indications, providing revenue growth along with other...

      Related Stories 

Regeneron Wades Deeper Into Oncology With Ambitions To Be A Force In The Space

Thu, 02/06/2020 - 11:23am

Senior VP-global clinical development David Weinreich addresses the company's growing investment in oncology drug development, why Regeneron is well positioned...

      Related Stories 

Sanofi Highlights MS Asset After Solid Q4

Thu, 02/06/2020 - 9:36am

The French drugmaker ended 2019 with a solid Q4 performance and news that its BTK inhibitor SAR442168 will start Phase...

      Related Stories 

Coronavirus Notebook: Gilead Readies Remdesivir, China Expedites Clinical Approvals

Thu, 02/06/2020 - 3:52am

Gilead is ramping up preparations to scale up remdesivir production, as China’s Genetic Materials Management Office expedites approvals for antiviral...

      Related Stories 

Best Practices In Seasonal Vaccine Efficacy Studies: Tips For Successful Planning And Execution

Thu, 02/06/2020 - 1:45am

Classical, randomized placebo-controlled efficacy studies of vaccines for seasonal illnesses, such as influenza and respiratory syncytial virus (RSV), must conform...

      Related Stories 

Executives On The Move: Bayer Names Upcoming Information Chief And Legal Hires At Eli Lilly And CytoDyn

Thu, 02/06/2020 - 1:08am

Stryker tech officer will become Bayer AG’s chief information technology and digital transformation Officer in June. In addition, monoclonal antibody...

      Related Stories 

Zydus Cadila Explores Orphan Drug Indication For NASH Candidate

Wed, 02/05/2020 - 7:46pm

Cadila is exploring orphan indications for saroglitazar magnesium, in addition to the approaching Phase III NASH clinical trials for its...

      Related Stories 

Biogen's Tecfidera Safe Following IPR Decision – For Now

Wed, 02/05/2020 - 2:30pm

Tecfidera accounts for nearly one-third of Biogen's revenues, so the patent decision relieves one overhang for the company. However, other...


Merck: It’s Not Just Keytruda Driving Future Growth

Wed, 02/05/2020 - 1:54pm

The company will depend on Keytruda for growth after spinning out some franchises, but executives argued during its Q4 earnings...

      Related Stories 

Merck To Spin Out A New Company, Following Industry's Downsizing Trend

Wed, 02/05/2020 - 11:32am

Merck will spinout its mature franchises, including women's health products, into a new company that will have about $6bn-$6.5bn in...

      Related Stories 

Pharma Is Priority As GSK Confirms Split With Consumer

Wed, 02/05/2020 - 8:19am

With CEO Emma Walmsley determined to keep investing in new technologies, GlaxoSmithKline has launched a two-year program to prepare for...

      Related Stories 

Novo Nordisk’s Positive Q4 Update Highlights Pipeline Plans

Wed, 02/05/2020 - 7:53am

Novo Nordisk used a solid Q4 update to confirm it will progress its investigative once-weekly basal insulin to Phase III.

      Related Stories 

Cell And Gene Therapy Manufacturing: Catalent Snaps Up MaSTherCell

Wed, 02/05/2020 - 7:25am

Consolidation and acquisitions among contract manufacturers of cell and gene therapies is a growing trend, as Catalent acquires Belgium- and...

      Related Stories 

Roche Has Blockbusters In Its Pipeline – But Demurs On Predicting Hits

Wed, 02/05/2020 - 4:08am

Biosimilars will take a bigger bite out of revenues in 2020 but Roche should score some hits from its broad...

      Related Stories